Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for AF Prevention in Cardiac Surgery
NCT02617069Phase 3Unknown
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- Sep 2015
- Primary completion
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of neuronox in Atrial fibrillation (AFib), sponsored by E. Meshalkin National Medical Research Centre. Status: unknown.
02
Drugs
neuronox
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02617069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02617069.